Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue
Total Revenue	$ 6,543,432	$ 2,065,825	$ 12,150,346	$ 5,030,996
Operating Expenses
Cost of Sales	2,607,950	1,609,223	6,305,804	3,992,926
General and Administrative	8,611,512	2,582,881	10,926,830	3,588,524
Inventory Written Off		(2,009)
Total Operating Expenses	11,219,462	4,190,095	17,232,634	7,581,450
Operating Losses from Operations	(4,676,030)	(2,124,270)	(5,082,288)	(2,550,454)
Other Income (Expense)
Interest Income	25,656	14,609	56,288	34,027
Interest Expense	(262,703)	(79,585)	(316,285)	(140,516)
Foreign Exchange Rate Transaction Gain (Loss)	958,334	(796,709)	2,421,031	1,463,773
Unrealized (Loss) Gain on Securities Investment	(21,168,905)	1,103,064	(30,703,914)	1,561,486
Realized Gain on Securities Investment	555,206	26,395	296,961	26,395
Loss on Investment on Security by Equity Method	(77,459)	(140,740)	(102,306)	(140,740)
Finance Income (Costs)	(50,261,203)	347	(50,844,071)	(4,890)
Other Income	19,044	38,413	30,300	43,884
Total Other Income (Expense), Net	(70,212,030)	165,794	(79,161,996)	2,843,419
Net (Loss) Income Before Income Taxes	(74,888,060)	(1,958,476)	(84,244,284)	292,965
Income Tax Expense	(1,264)	(114,653)	(452,601)	(114,653)
Net (Loss) Income	(74,889,324)	(2,073,129)	(84,696,885)	178,312
Loss from Discontinued Operations, Net of Tax		(361,385)		(361,385)
Net Loss	(74,889,324)	(2,434,514)	(84,696,885)	(183,073)
Net Loss Attributable to Non-Controlling Interest	(8,238,460)	(1,269,460)	(11,807,572)	(633,021)
Net (Loss) Income Attributable to Common Stockholders	(66,650,864)	(1,165,054)	(72,889,313)	449,948
Other Comprehensive Income (Loss), Net
Unrealized Gain (Loss) on Securities Investment	(35,922)	13,115	(37,909)	516
Foreign Currency Translation Adjustment	(1,070,191)	626,872	(2,839,631)	(1,047,149)
Comprehensive Loss	(75,995,437)	(1,433,142)	(87,574,425)	(1,229,706)
Comprehensive Loss Attributable to Non-controlling Interests	(8,584,838)	(1,054,420)	(12,913,762)	(1,001,551)
Comprehensive Loss Attributable to Common Stockholders	$ (67,410,599)	$ (378,722)	$ (74,660,663)	$ (228,155)
Net (Loss) Income Per Share - Basic and Diluted
Continuing Operations	$ (6.03)	$ (0.08)	$ (7.42)	$ 0.08
Discontinued Operations		(0.04)		(0.03)
Net Income (Loss) Per Share	$ (6.03)	$ (0.12)	$ (7.42)	$ 0.05
Weighted Average Common Shares Outstanding - Basic and Diluted	11,056,534	9,758,236	9,824,059	9,880,967
Property Sales [Member]
Revenue
Total Revenue	$ 4,584,542	$ 2,047,405	$ 8,478,673	$ 5,001,794
Biohealth Property Sales [Member]
Revenue
Total Revenue	$ 1,958,890	$ 18,420	$ 3,671,673	$ 29,202